PHAT
Phathom Pharmaceuticals Inc
7.30$
+3.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | +180.4% | +283.1% | +123.3% | +81.4% | -3.9% | +38.5% | +25.3% | +16.3% | +1.2% | +27.4% | – | |
| – | +190.9% | +21.0% | +223.0% | +71.2% | +61.9% | -2.4% | +35.3% | +22.9% | +23.6% | +56.9% | +25.8% | – | |
| – | – | +350.3% | +300.3% | +135.3% | +84.7% | -4.1% | +39.0% | +25.7% | +15.3% | -7.3% | +27.8% | – | |
| – | +9.2% | -29.6% | -21.8% | +17.9% | -1.3% | +7.0% | -1.2% | -22.6% | +6.6% | +3.7% | +0.5% | – | |
| – | +160.4% | +0.0% | +24.5% | +0.3% | -0.3% | +24.5% | -9.7% | -39.6% | -6.2% | +11.7% | +2.4% | – | |
| – | +97.5% | +1.8% | +16.5% | +1.9% | +0.6% | +21.6% | -8.9% | -37.9% | -4.6% | +10.6% | +2.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +28.9% | +31.8% | +3.5% | +4.1% | +0.6% | -2.8% | -3.1% | -8.0% | +1.9% | -3.8% | -4.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -330.4% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.